Application A1170 - Rebaudioside MD as a Steviol Glycosides from Saccharomyces cerevisiae - Approval Report

Food Standards Australia New Zealand (FSANZ) has assessed an application made by Cargill Incorporated to include a new specification for a steviol glycoside mixture of rebaudiosides M and D (Reb MD), produced from a genetically modified Saccharomyces cerevisiae strain. On 2 April 2019, FSANZ sought submissions on a draft variation and published an associated report. FSANZ received ten submissions. FSANZ approved the draft variation on 12 June 2019. The Australia and New Zealand Ministerial Forum on Food Regulation was notified of FSANZ’s decision on 20 June 2019.